マーケットレポート詳細

3Dバイオプリンティングの世界市場:2027年に至るバイオプリンタ/インク別、用途別予測

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027

出版元:MarketsandMarkets   出版元について
発行年:2022年7月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文259ページになります。
商品コード:MAM2987

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

3Dバイオプリンティングの世界市場規模は2022年で13億ドル、2027年に33億ドル、市場の平均年成長率は20.8%に到達すると推測されます。 市場の成長要因としては、3Dバイオプリンターやバイオマテリアルの技術的進歩、製薬・美容業界における3Dバイオプリンティングの利用増加、バイオプリンティング研究活動を支援する公的及び民間資金の増加などが挙げられます。一方で、有能な専門家の不足、高い開発・生産コストなどの要因が、同市場の成長を妨げています。
レポートは3Dバイオプリンティングの世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(コンポーネント別市場、マテリアル別市場、等)を中心に構成されています。また競合状況、主要企業情報(15社)、エコシステム分析、市場シェア分析などの分析も加味し、3Dバイオプリンティング市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆3Dバイオプリンティングの世界市場予測2020-2027年

・市場規模(US$)

◆コンポーネント別、市場-2027年

3Dバイオプリンター
・マイクロ押出バイオプリンティング
・インクジェット3Dバイオプリンティング
・レーザアシスト式バイオプリンティング
・光造形法式バイオプリンティング
・磁気3Dバイオプリンティング
・その他技術

バイオインク
・天然バイオインク
・ハイブリッドバイオインク
・合成バイオインク
※(市場規模US$)

◆マテリアル別、市場-2027年

・生細胞
・ヒドロゲル
・細胞外マトリックス
・その他バイオマテリアル
※(市場規模US$)

◆用途別、市場-2027年

研究用途
・医薬品研究
・再生医療
・3D細胞培養
臨床用途
・皮膚
・骨/軟骨
・血管
・その他臨床用途
※(市場規模US$)

◆エンドユーザー別、市場-2027年

・研究機関/学術機関
・バイオ医薬品企業
・病院
※(市場規模US$)

◆主要国地域別市場-2027年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、韓国
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19の影響
・技術分析
・特許分析
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・規制分析
・ファイブフォース分析
・市場シェア分析
・競合状況

◆3Dバイオプリンティングの主要企業プロフィール動向

・BICO GROUP AB
・ORGANOVO HOLDINGS INC.
・ALLEVI, INC. (PART OF 3D SYSTEMS, INC.)
・COLLPLANT BIOTECHNOLOGIES LTD.
・REGENHU
・ENVISIONTEC GMBH (PART OF DESKTOP METAL, INC.)
・ASPECT BIOSYSTEMS LTD.
・ADVANCED SOLUTIONS LIFE SCIENCES, LLC
・CYFUSE BIOMEDICAL K.K.
・ROKIT HEALTHCARE, INC.
・REGENOVO BIOTECHNOLOGY CO., LTD. (PART OF SHINING 3D TECH CO., LTD.)
・PANDORUM TECHNOLOGIES PVT. LTD.
・FOLDINK LIFE SCIENCE TECHNOLOGIES
・REVOTEK CO., LTD.
・PRECISE BIO

(その他企業)
・BRINTER
・PRELLIS BIOLOGICS
・REGEMAT 3D
・3DBIO THERAPEUTICS
・TISSUE REGENERATION SYSTEMS INC.
・POIETIS
・SUNP BIOTECH, LLC
・VIVAX BIO, LLC
・GESIM MBH
・MANCHESTER BIOGEL

(全259頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.2.1               INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3            MARKET SCOPE
1.3.1               MARKETS COVERED
1.3.2               YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            LIMITATIONS
1.6            STAKEHOLDERS
1.7            SUMMARY OF CHANGES

2      RESEARCH METHODOLOGY

2.1            RESEARCH DATA
・     FIGURE 1             RESEARCH DESIGN   42
2.1.1               SECONDARY DATA
2.1.1.1             KEY DATA FROM SECONDARY SOURCES
2.1.2               PRIMARY DATA
・     FIGURE 2             BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET
2.2            MARKET ESTIMATION METHODOLOGY
・     FIGURE 3             3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
・     FIGURE 4             MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
2.2.1               INSIGHTS FROM PRIMARY EXPERTS
・     FIGURE 5             MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3            MARKET GROWTH RATE PROJECTIONS
・     FIGURE 6             3D BIOPRINTING MARKET (SUPPLY SIDE): CAGR PROJECTIONS
・     FIGURE 7             3D BIOPRINTING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF
DEMAND-SIDE FACTORS
2.4            DATA TRIANGULATION
・     FIGURE 8             DATA TRIANGULATION METHODOLOGY
2.5            RESEARCH ASSUMPTIONS
2.5.1               COVID-19-SPECIFIC ASSUMPTIONS
2.6            RISK ANALYSIS

3      EXECUTIVE SUMMARY

・     FIGURE 9             3D BIOPRINTING MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
・     FIGURE 10           3D BIOPRINTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
・     FIGURE 11           3D BIOPRINTING MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION)
・     FIGURE 12           3D BIOPRINTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
・     FIGURE 13           GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET

4      PREMIUM INSIGHTS

4.1            3D BIOPRINTING MARKET OVERVIEW
・     FIGURE 14           TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTING INDUSTRY
TO DRIVE MARKET
4.2            NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2021)
・     FIGURE 15           US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D BIOPRINTING MARKET IN 2021
4.3            3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2022 VS. 2027
・     FIGURE 16           LIVING CELLS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
4.4            3D BIOPRINTING MARKET SHARE, BY END USER, 2022
・     FIGURE 17           RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE LARGEST
END USERS OF 3D BIOPRINTING MARKET
4.5            3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     FIGURE 18           ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH FROM
2022 TO 2027

5      MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
・     FIGURE 19           3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES
5.2.1               DRIVERS
5.2.1.1             INCREASING USE OF 3D BIOPRINTING IN PHARMACEUTICAL AND COSMETOLOGY INDUSTRIES
5.2.1.2             DEVELOPMENTS IN 3D BIOPRINTING FOR TISSUE AND ORGAN REGENERATION APPLICATIONS
5.2.1.3             RISING PUBLIC AND PRIVATE FUNDING TO SUPPORT BIOPRINTING RESEARCH ACTIVITIES
5.2.1.4             TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTING INDUSTRY
5.2.2               RESTRAINTS
5.2.2.1             DEARTH OF SKILLED PROFESSIONALS
5.2.2.2             HIGH DEVELOPMENT AND PRODUCTION COSTS
5.2.2.3             LACK OF REGULATORY GUIDELINES GOVERNING 3D BIOPRINTING
5.2.3               OPPORTUNITIES
5.2.3.1             RISING DEMAND FOR ORGAN TRANSPLANT
5.2.3.2             GROWING AWARENESS OF 3D BIOPRINTING
5.2.3.3             GROWING DEMAND FOR REGENERATIVE MEDICINE AND STEM CELL RESEARCH   64
5.2.4               CHALLENGES
5.2.4.1             SOCIOETHICAL CONCERNS RELATED TO USE OF 3D-BIOPRINTED PRODUCTS
5.2.4.2             HIGH COST OF 3D BIOPRINTING
5.2.4.3             PROCESS CONTROL AND UNDERSTANDING OF 3D BIOPRINTERS

5.3            RANGES/SCENARIOS
・     FIGURE 20           SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
ON GROWTH OF 3D BIOPRINTING MARKET
5.4            IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
・     FIGURE 21           3D BIOPRINTING MARKET SCENARIO PRE- AND POST-COVID-19,
2020–2022
・     FIGURE 22           TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5            PRICING ANALYSIS
5.6            TECHNOLOGY ANALYSIS
・     TABLE 1               COMPARISON OF BIOPRINTING TECHNIQUES
・     TABLE 2               ADVANTAGES AND DISADVANTAGES OF 3D BIOPRINTING TECHNIQUES
5.7            PATENT ANALYSIS
・     FIGURE 23           PATENT APPLICATIONS FOR 3D BIOPRINTING MARKET,
JANUARY 2011–MAY 2022
・     TABLE 3               INDICATIVE LIST OF PATENTS IN 3D BIOPRINTING MARKET
5.8            VALUE CHAIN ANALYSIS
・     FIGURE 24           VALUE CHAIN ANALYSIS OF 3D BIOPRINTING MARKET: RAW MATERIAL
AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE
5.8.1               RESEARCH & DEVELOPMENT (R&D)
5.8.2               MANUFACTURING & ASSEMBLY
5.8.3               DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.9            SUPPLY CHAIN ANALYSIS
5.9.1               PROMINENT COMPANIES
5.9.2               SMALL AND MEDIUM-SIZED ENTERPRISES (SMES)
5.9.3               END USERS
・     FIGURE 25           3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS
5.10          ECOSYSTEM ANALYSIS OF 3D BIOPRINTING MARKET
・     TABLE 4               SUPPLY CHAIN ECOSYSTEM
5.11          KEY CONFERENCES AND EVENTS IN 2022–2023
・     TABLE 5               3D BIOPRINTING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12          REGULATORY ANALYSIS
5.12.1             REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 6               NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 7               EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
・     TABLE 8               ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
・     TABLE 9               REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13          PORTER’S FIVE FORCES ANALYSIS
・     TABLE 10             3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1             THREAT OF NEW ENTRANTS
5.13.2             THREAT OF SUBSTITUTES
5.13.3             BARGAINING POWER OF SUPPLIERS
5.13.4             BARGAINING POWER OF BUYERS
5.13.5             COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.14          KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1             KEY STAKEHOLDERS IN BUYING PROCESS
・     FIGURE 26           INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF
3D BIOPRINTING PRODUCTS
5.14.2             BUYING CRITERIA FOR 3D BIOPRINTING PRODUCTS
・     FIGURE 27           KEY BUYING CRITERIA FOR END USERS

6      3D BIOPRINTING MARKET, BY COMPONENT

6.1            INTRODUCTION
・     TABLE 11             3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
6.2            3D BIOPRINTERS
6.2.1               3D BIOPRINTERS MARKET, BY TECHNOLOGY
・     TABLE 12             3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 13             3D BIOPRINTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 14             NORTH AMERICA: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 15             EUROPE: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 16             ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.1             MICROEXTRUSION BIOPRINTING
6.2.1.1.1             INCREASING RESEARCH IN MICROEXTRUSION FUELING ADOPTION
OF THIS TECHNOLOGY
・     TABLE 17             MICROEXTRUSION 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 18             NORTH AMERICA: MICROEXTRUSION 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 19             EUROPE: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 20             ASIA PACIFIC: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.1.2             INKJET 3D BIOPRINTING
6.2.1.2.1             HIGH CELL VIABILITY AND LOW COST RESULTED IN INCREASED DEMAND FOR INKJET 3D BIOPRINTING
・     TABLE 21             INKJET 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 22             NORTH AMERICA: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 23             EUROPE: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 24             ASIA PACIFIC: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.3             LASER-ASSISTED BIOPRINTING
6.2.1.3.1             LASER-ASSISTED BIOPRINTING AMONG HIGHEST-RESOLUTION BIOPRINTING TECHNOLOGIES AVAILABLE IN 3D BIOPRINTING INDUSTRY
・     TABLE 25             LASER-ASSISTED 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 26             NORTH AMERICA: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
・     TABLE 27             EUROPE: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 28             ASIA PACIFIC: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
6.2.1.4             STEREOLITHOGRAPHY-BASED BIOPRINTING
6.2.1.4.1             STEREOLITHOGRAPHY OFFERS HIGH PRINTING QUALITY, SPEED,
AND CELL VIABILITY
・     TABLE 29             STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 30             NORTH AMERICA: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 31             EUROPE: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 32             ASIA PACIFIC: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.5             MAGNETIC 3D BIOPRINTING
6.2.1.5.1             ACCURACY AND SPEED ARE MAJOR ADVANTAGES OF MAGNETIC
3D BIOPRINTING
・     TABLE 33             MAGNETIC 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 34             NORTH AMERICA: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 35             EUROPE: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 36             ASIA PACIFIC: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.6             OTHER TECHNOLOGIES
・     TABLE 37             3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 38             NORTH AMERICA: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 39             EUROPE: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 40             ASIA PACIFIC: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION)
6.3            BIOINKS
・     TABLE 41             BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 42             BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 43             NORTH AMERICA: BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 44             EUROPE: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 45             ASIA PACIFIC: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

6.3.1               NATURAL BIOINKS  100
6.3.1.1             NATURAL BIOINKS MOST PREFERRED BIOINK IN 3D BIOPRINTING PROCESS  100
・     TABLE 46             NATURAL BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 47             NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 48             EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 49             ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.2               HYBRID BIOINKS
6.3.2.1             HYBRID BIOINKS POSSESS HIGH MECHANICAL STRENGTH AND BIOCOMPATIBILITY
・     TABLE 50             HYBRID BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 51             NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 52             EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 53             ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.3               SYNTHETIC BIOINKS  104
6.3.3.1             IMPROVED MECHANICAL STRENGTH AND CONSISTENCY OFFERED
BY SYNTHETIC BIOINKS TO DRIVE MARKET
・     TABLE 54             SYNTHETIC BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 55             NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 56             EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 57             ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)

7      3D BIOPRINTING MARKET, BY MATERIAL

7.1            INTRODUCTION
・     TABLE 58             3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
7.2            LIVING CELLS
7.2.1               ETHICAL ISSUES ASSOCIATED WITH USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH
・     TABLE 59             3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 60             NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 61             EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 62             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)

7.3            HYDROGELS
7.3.1               DYNAMIC PROPERTIES OF HYDROGELS SUPPORT THEIR ADOPTION
IN 3D TISSUE ENGINEERING
・     TABLE 63             3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 64             NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 65             EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 66             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4            EXTRACELLULAR MATRICES
7.4.1               ECM HAS EMERGED AS PROMISING TOOL IN TISSUE ENGINEERING
・     TABLE 67             3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 68             NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 69             EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 70             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES,
BY COUNTRY, 2020–2027 (USD MILLION)
7.5            OTHER BIOMATERIALS
・     TABLE 71             3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 72             NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 73             EUROPE: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 74             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION)

8      3D BIOPRINTING MARKET, BY APPLICATION

8.1            INTRODUCTION
・     TABLE 75             3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2            RESEARCH APPLICATIONS
・     TABLE 76             3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 77             3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 78             NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 79             EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 80             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1               DRUG RESEARCH
8.2.1.1             DRUG RESEARCH IS LARGEST AND FASTEST-GROWING SEGMENT OF
3D BIOPRINTING MARKET
・     TABLE 81             3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 82             NORTH AMERICA: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 83             EUROPE: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 84             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2               REGENERATIVE MEDICINE
8.2.2.1             GROWING DEMAND FOR ORGAN TRANSPLANT TO SUPPORT MARKET GROWTH
・     TABLE 85             3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 86             NORTH AMERICA: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 87             EUROPE: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 88             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3               3D CELL CULTURE  127
8.2.3.1             RISING FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO DRIVE MARKET FOR 3D CELL CULTURE
・     TABLE 89             3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 90             NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 91             EUROPE: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 92             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
8.3            CLINICAL APPLICATIONS
・     TABLE 93             3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 94             3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 95             NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 96             EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 97             ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.1               SKIN
8.3.1.1             GROWING NUMBER OF AESTHETIC AND RECONSTRUCTION SURGERIES TO PROPEL MARKET GROWTH
・     TABLE 98             3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 99             NORTH AMERICA: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 100           EUROPE: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 101           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.2               BONE AND CARTILAGE
8.3.2.1             INCREASING INCIDENCE OF MUSCULOSKELETAL CONDITIONS TO DRIVE DEMAND FOR BONE GRAFTS
・     TABLE 102           3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 103           NORTH AMERICA: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 104           EUROPE: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 105           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.3               BLOOD VESSELS
8.3.3.1             INCREASING RESEARCH ACTIVITIES FOCUSED ON 3D BIOPRINTING OF BLOOD VESSELS MAJOR FACTOR DRIVING MARKET
・     TABLE 106           3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 107           NORTH AMERICA: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 108           EUROPE: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 109           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.4               OTHER CLINICAL APPLICATIONS
・     TABLE 110           LIST OF ONGOING CLINICAL TRIALS
・     TABLE 111           3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 112           NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 113           EUROPE: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 114           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)

9      3D BIOPRINTING MARKET, BY END USER

9.1            INTRODUCTION
・     TABLE 115           3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2            RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
9.2.1               RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE FASTEST-GROWING END USERS OF 3D BIOPRINTING MARKET
・     TABLE 116           3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 117           NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 118           EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 119           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3            BIOPHARMACEUTICAL COMPANIES
9.3.1               INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF 3D BIOPRINTING
・     TABLE 120           3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 121           NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 122           EUROPE: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 123           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.4            HOSPITALS
9.4.1               3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS
・     TABLE 124           3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 125           NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 126           EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 127           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)

10   3D BIOPRINTING MARKET, BY REGION

10.1          INTRODUCTION
・     TABLE 128           3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2          NORTH AMERICA
・     FIGURE 28           NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
・     TABLE 129           NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 130           NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 131           NORTH AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 132           NORTH AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 133           NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 134           NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 135           NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 136           NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 137           NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1             US
10.2.1.1           US DOMINATES GLOBAL 3D BIOPRINTING MARKET
・     TABLE 138           US: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 139           US: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 140           US: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 141           US: 3D BIOINKS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 142           US: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

・     TABLE 143           US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 144           US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 145           US: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2             CANADA
10.2.2.1           GOVERNMENT INITIATIVES TO SUPPORT GROWTH OF 3D BIOPRINTING MARKET IN CANADA
・     TABLE 146           CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 147           CANADA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 148           CANADA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 149           CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 150           CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 151           CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 152           CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 153           CANADA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3          EUROPE
・     TABLE 154           EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 155           EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 156           EUROPE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 157           EUROPE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 158           EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 159           EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 160           EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 161           EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 162           EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1             GERMANY
10.3.1.1           INCREASING DEMAND FOR ORGAN TRANSPLANT TO DRIVE MARKET
・     TABLE 163           GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 164           GERMANY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 165           GERMANY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 166           GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 167           GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 168           GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 169           GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 170           GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2             UK
10.3.2.1           INCREASED FUNDING AND GRANTS TO SUPPORT RESEARCH ACTIVITIES RELATED TO 3D BIOPRINTING IN UK
・     TABLE 171           UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 172           UK: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 173           UK: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 174           UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 175           UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 176           UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 177           UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 178           UK: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3             FRANCE
10.3.3.1           RISING ADOPTION OF 3D BIOPRINTING TECHNOLOGY TO PROPEL MARKET GROWTH
・     TABLE 179           FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 180           FRANCE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 181           FRANCE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 182           FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 183           FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 184           FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 185           FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 186           FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4             ITALY
10.3.4.1           ITALY IS LEADING LIFE SCIENCE RESEARCH HUB IN EUROPE
・     TABLE 187           ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 188           ITALY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 189           ITALY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 190           ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 191           ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 192           ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 193           ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 194           ITALY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5             SPAIN
10.3.5.1           INCREASING FUNDING FROM PRIVATE AND PUBLIC ORGANIZATIONS TO AID MARKET GROWTH IN SPAIN
・     TABLE 195           SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 196           SPAIN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 197           SPAIN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 198           SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 199           SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 200           SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 201           SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 202           SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6             REST OF EUROPE
・     TABLE 203           ROE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 204           ROE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 205           ROE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 206           ROE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 207           ROE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 208           ROE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 209           ROE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 210           ROE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4          ASIA PACIFIC
・     FIGURE 29           ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
・     TABLE 211           ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 212           ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 213           ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 214           ASIA PACIFIC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 215           ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 216           ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 217           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 218           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 219           ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1             CHINA
10.4.1.1           MARKET IN CHINA PROJECTED TO REGISTER SIGNIFICANT GROWTH OWING TO RISING REGENERATIVE MEDICINE RESEARCH
・     TABLE 220           CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 221           CHINA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 222           CHINA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 223           CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 224           CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 225           CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 226           CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 227           CHINA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2             JAPAN
10.4.2.1           STRONG RESEARCH BASE AND GOVERNMENT SUPPORT TO DRIVE MARKET FOR 3D BIOPRINTING IN JAPAN
・     TABLE 228           JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 229           JAPAN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 230           JAPAN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 231           JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 232           JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 233           JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 234           JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 235           JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3             INDIA
10.4.3.1           INITIATIVES TO RAISE AWARENESS AND DEVELOP NOVEL PRODUCTS TO SUPPORT MARKET GROWTH
・     TABLE 236           INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 237           INDIA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 238           INDIA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 239           INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 240           INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 241           INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 242           INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 243           INDIA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4             SOUTH KOREA
10.4.4.1           INCREASED AWARENESS ABOUT 3D BIOPRINTING TO DRIVE MARKET IN SOUTH KOREA
・     TABLE 244           SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 245           SOUTH KOREA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 246           SOUTH KOREA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 247           SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 248           SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 249           SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 250           SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 251           SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5             REST OF ASIA PACIFIC
・     TABLE 252           ROAPAC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 253           ROAPAC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 254           ROAPAC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 255           ROAPAC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 256           ROAPAC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 257           ROAPAC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 258           ROAPAC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 259           ROAPAC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5          LATIN AMERICA
10.5.1             GROWING MEDICAL TOURISM TO DRIVE MARKET FOR 3D BIOPRINTING IN LATIN AMERICA
・     TABLE 260           LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 261           LATIN AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 262           LATIN AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 263           LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 264           LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 265           LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)

・     TABLE 266           LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 267           LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6          MIDDLE EAST AND AFRICA
10.6.1             GROWING RESEARCH EFFORTS TO BOOST MARKET GROWTH
・     TABLE 268           MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・     TABLE 269           MIDDLE EAST AND AFRICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
・     TABLE 270           MIDDLE EAST AND AFRICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 271           MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
・     TABLE 272           MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・     TABLE 273           MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 213
・     TABLE 274           MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 214
・     TABLE 275           MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)

11   COMPETITIVE LANDSCAPE

11.1          OVERVIEW
11.2          KEY PLAYER STRATEGIES/RIGHT TO WIN
・     FIGURE 30           KEY DEVELOPMENTS IN 3D BIOPRINTING MARKET, 2019–2022
11.3          MARKET SHARE ANALYSIS
・     FIGURE 31           3D BIOPRINTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
・     TABLE 276           3D BIOPRINTING MARKET: DEGREE OF COMPETITION
11.4          REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・     FIGURE 32           REVENUE SHARE ANALYSIS OF TOP PLAYERS IN 3D BIOPRINTING MARKET, 2019–2021
11.5          COMPANY EVALUATION QUADRANT
11.5.1             STARS
11.5.2             EMERGING LEADERS
11.5.3             PERVASIVE PLAYERS  218
11.5.4             PARTICIPANTS
・     FIGURE 33           3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT, 2021
11.6          COMPANY EVALUATION QUADRANT: STARTUPS/SMES
11.6.1             PROGRESSIVE COMPANIES
11.6.2             STARTING BLOCKS
11.6.3             RESPONSIVE COMPANIES
11.6.4             DYNAMIC COMPANIES
・     FIGURE 34           3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
11.7          COMPANY FOOTPRINT ANALYSIS
11.7.1             PRODUCT FOOTPRINT OF COMPANIES
・     TABLE 277           PRODUCT FOOTPRINT OF COMPANIES IN 3D BIOPRINTING MARKET (2021)
11.7.2             REGIONAL FOOTPRINT OF COMPANIES
・     TABLE 278           REGIONAL FOOTPRINT OF COMPANIES IN 3D BIOPRINTING MARKET (2021)
11.8          COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
・     TABLE 279           3D BIOPRINTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
11.9          COMPETITIVE SCENARIO
・     TABLE 280           KEY PRODUCT LAUNCHES
・     TABLE 281           KEY DEALS
・     TABLE 282           OTHER KEY DEVELOPMENTS

12   COMPANY PROFILES

12.1          KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES, WEAKNESSES AND COMPETITIVE THREATS)*
12.1.1             BICO GROUP AB
・     TABLE 283           BICO GROUP AB: BUSINESS OVERVIEW
・     FIGURE 35           BICO GROUP AB: COMPANY SNAPSHOT (2021)
12.1.2             ORGANOVO HOLDINGS INC.
・     TABLE 284           ORGANOVO HOLDINGS INC.: BUSINESS OVERVIEW
・     FIGURE 36           ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2020)
12.1.3             ALLEVI, INC. (PART OF 3D SYSTEMS, INC.)
・     TABLE 285           3D SYSTEMS, INC.: BUSINESS OVERVIEW
・     FIGURE 37           3D SYSTEMS, INC.: COMPANY SNAPSHOT (2021)
12.1.4             COLLPLANT BIOTECHNOLOGIES LTD.
・     TABLE 286           COLLPLANT BIOTECHNOLOGIES LTD.: BUSINESS OVERVIEW
・     FIGURE 38           COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2021)
12.1.5             REGENHU
・     TABLE 287           REGENHU: BUSINESS OVERVIEW   241
12.1.6             ENVISIONTEC GMBH (PART OF DESKTOP METAL, INC.)
・     TABLE 288           ENVISIONTEC GMBH: BUSINESS OVERVIEW
12.1.7             ASPECT BIOSYSTEMS LTD.
・     TABLE 289           ASPECT BIOSYSTEMS LTD.: BUSINESS OVERVIEW
12.1.8             ADVANCED SOLUTIONS LIFE SCIENCES, LLC
・     TABLE 290           ADVANCED SOLUTIONS LIFE SCIENCES, LLC: BUSINESS OVERVIEW
12.1.9             CYFUSE BIOMEDICAL K.K.
・     TABLE 291           CYFUSE BIOMEDICAL K.K.: BUSINESS OVERVIEW
12.1.10          ROKIT HEALTHCARE, INC.
・     TABLE 292           ROKIT HEALTHCARE, INC.: BUSINESS OVERVIEW
12.1.11          REGENOVO BIOTECHNOLOGY CO., LTD. (PART OF SHINING 3D TECH CO., LTD.)
・     TABLE 293           REGENOVO BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.1.12          PANDORUM TECHNOLOGIES PVT. LTD.
・     TABLE 294           PANDORUM TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
12.1.13          FOLDINK LIFE SCIENCE TECHNOLOGIES
・     TABLE 295           FOLDINK LIFE SCIENCE TECHNOLOGIES: BUSINESS OVERVIEW
12.1.14          REVOTEK CO., LTD. 254
・     TABLE 296           REVOTEK CO., LTD.: BUSINESS OVERVIEW
12.1.15          PRECISE BIO
・     TABLE 297           PRECISE BIO: BUSINESS OVERVIEW
12.2          OTHER PLAYERS
12.2.1             BRINTER
12.2.2             PRELLIS BIOLOGICS  256
12.2.3             REGEMAT 3D
12.2.4             3DBIO THERAPEUTICS
12.2.5             TISSUE REGENERATION SYSTEMS INC.
12.2.6             POIETIS
12.2.7             SUNP BIOTECH, LLC  259
12.2.8             VIVAX BIO, LLC
12.2.9             GESIM MBH
12.2.10          MANCHESTER BIOGEL  261
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES, WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

13   APPENDIX

13.1          DISCUSSION GUIDE
13.2          KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3          AVAILABLE CUSTOMIZATION
13.4          RELATED REPORTS
13.5          AUTHOR DETAILS


△ 一番上に戻る